Logo
x

Search

Subscribe Now

Health Canada Approval

BeiGene's Brukinsa (Zanubrutinib) Receives Health Canada's Approval for Mantle Cell Lymphoma

BeiGene's Brukinsa (Zanubrutinib) Receives Health Canada's Approval for Mantle Cell Lymphoma

  • July 27, 2021
Lilly's Taltz (ixekizumab) Receives Health Canada Approval for Non-Radiographic Axial Spondyloarthritis

Lilly's Taltz (ixekizumab) Receives Health Canada Approval for Non-Radiographic Axial Spondyloarthritis

  • October 21, 2020
BMS' Zeposia (ozanimod) Receives Health Canada Approval for Relapsing Remitting Multiple Sclerosis

BMS' Zeposia (ozanimod) Receives Health Canada Approval for Relapsing Remitting Multiple Sclerosis

  • October 8, 2020
BMS's Reblozyl (luspatercept) Receives Health Canada Approval for Beta Thalassemia

BMS's Reblozyl (luspatercept) Receives Health Canada Approval for Beta Thalassemia

  • September 30, 2020
UCB's Cimzia (certolizumab pegol) Receives Health Canada Approval for Non-Radiographic Axial Spondyloarthritis

UCB's Cimzia (certolizumab pegol) Receives Health Canada Approval for Non-Radiographic Axial Spondyloarthritis

  • January 16, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.